4-(2-Aminopyrimidin-4-yl)benzoic acid, 97.0%, 250mg

2-ETHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIAZOLE, 95.0%, 250mg

(2-(Aminomethyl)phenyl)methanol, 98.0%, 10g

(7R,8aS)-7-aminohexahydropyrrolo[1,2-a]pyrazine-1,4-dione hydrochloride, 95.0%, 5g

2-{[(4-fluorophenyl)amino]methyl}phenol, 95+%, 250mg

4-bromo-3-fluoro-2-methylphenol, 95.0%, 1g

Benzamide, N-[2-[(3S)-3-[[4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, 98%, 100mg

4-(2,2-Bis(4-methoxyphenyl)-1-phenylvinyl)benzaldehyde, 98%, 250mg

1,4-Phenylene di-tert-butyl bis(carbonate), 98%, 250mg

Refractometer for Clinical Applications. Digital

N-Carbobenzoxy-L-phenylalaninol>98.0%(HPLC)5g

8-Bromo-1,6-naphthyridine, 97.0%, 1g

1,5,6,7-Tetrahydro-2-methyl-4H-indol-4-one>98.0%(GC)25g